Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Cyclophosphamide 10 mg/ml Oral Suspension

FDA-approved generic
Dose form
Suspension
Active ingredients
Cyclophosphamide
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Save 15% on every refill when you enroll in Automatic Refills
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Cyclophosphamide
Suspension
6427079ea64324b1df51893f
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded suspension containing cyclophosphamide, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing cyclophosphamide are listed in injection, capsule and tablet forms. No finished cyclophosphamide product of any kind is listed in suspension form.

Storage category and dating

Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Cyclophosphamide is an alkylating chemotherapy and immunosuppressant medicine; compounded oral preparations such as suspensions require a prescription and are not FDA-approved.

About this ingredient

Cyclophosphamide is an alkylating drug of the nitrogen mustard type. It is a prodrug: liver enzymes convert it to phosphoramide mustard, which cross-links DNA and leads to cell death, and to acrolein, which has no antitumor activity but irritates the bladder. It also suppresses the immune system. Manufactured products include cyclophosphamide tablets, capsules and injection. The tablet label lists FDA-approved uses in malignant lymphomas, multiple myeloma, certain leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma and breast cancer, and in biopsy-confirmed minimal change nephrotic syndrome in children who did not respond to or cannot tolerate corticosteroids. A prescriber may order cyclophosphamide compounded as an oral liquid for a young child who cannot take tablets; a published stability study describes extemporaneous oral suspensions. NIOSH lists cyclophosphamide as a hazardous drug. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

The tablet label has no boxed warning but lists serious warnings: low blood counts and serious infections, bladder and kidney toxicity including bleeding in the bladder, heart damage, lung damage, new cancers, liver veno-occlusive disease, infertility, slowed wound healing and low sodium. Drink plenty of fluids and urinate often, and call your prescriber about blood in the urine, fever, chills, sore throat, shortness of breath or swelling. People with a severe allergy to cyclophosphamide or a blocked urinary tract should not take it. Protease inhibitors and other drugs that suppress blood counts or affect the heart can add to its toxicity. It can harm an unborn baby; the label advises pregnancy testing and contraception for both women and men. Do not breastfeed during treatment and for one week after the last dose (label; LactMed). Avoid touching broken tablets, and wash your hands right away if you do. For side effects, talk to your prescriber or pharmacist.

Cyclophosphamide is activated mainly in the liver by CYP2B6 and other CYP450 enzymes to 4-hydroxycyclophosphamide and aldophosphamide, which yields phosphoramide mustard (DNA cross-linking) and acrolein (urotoxicity). After oral dosing, peak concentrations occur at about one hour, and the oral to IV AUC ratio ranges from 0.87 to 0.96. Protein binding is about 20%, and 10 to 20% is excreted unchanged in urine; exposure rises as renal function declines. Labeled indications (cyclophosphamide tablets, Baxter): the malignancies listed above and pediatric minimal change nephrotic syndrome; safety in adult nephrotic syndrome has not been established. StatPearls describes immunosuppressive use in conditions such as severe multiple sclerosis and before transplant; these are not FDA-approved indications for the tablets. Kennedy and colleagues (St. Jude) reported refrigerated stability of extemporaneous suspensions made from cyclophosphamide injection in simple syrup or a commercial suspending vehicle, with much shorter stability at room temperature; beyond-use dating per pharmacist. Dosing per prescriber. Monitor complete blood counts, urinary sediment, hydration, cardiac and pulmonary status, sodium and liver function. NIOSH's 2024 List (Table 1) includes cyclophosphamide as an IARC Group 1 carcinogen with manufacturer special handling information; the label calls it cytotoxic and directs special handling and disposal procedures.

Sources

Using and storing

How it is used

Shake the bottle well before every dose so the medication is evenly mixed. Measure with the oral syringe or dosing cup provided, using the milliliter markings, and never a kitchen spoon. Take it by mouth as your label directs. Rinse the syringe after use and recap the bottle.

Storing it

Water-based suspensions are aqueous preparations. Under USP <795>, a preserved suspension usually carries a beyond-use date of up to 35 days at room temperature or refrigerated; an unpreserved one is refrigerated for up to 14 days. Oil-based suspensions are nonaqueous and may carry up to 90 days. Your label states storage and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Cyclophosphamide 10 mg/ml Oral Suspension
Suspension
30 mL
controlled

Take orally

Once daily